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Insights & Perspectives
Exaptive origins of regulated mRNA
decay in eukaryotes
Fursham M. Hamid1) and Eugene V. Makeyev1)2)*
Eukaryotic gene expression is extensively controlled at the level of mRNA
stability and the mechanisms underlying this regulation are markedly different
from their archaeal and bacterial counterparts. We propose that two such
mechanisms, nonsense-mediated decay (NMD) and motif-specific transcript
destabilization by CCCH-type zinc finger RNA-binding proteins, originated as a
part of cellular defense against RNA pathogens. These branches of the mRNA
turnover pathwaymight have been used by primeval eukaryotes alongside RNA
interference to distinguish their own messages from those of RNA viruses and
retrotransposable elements. We further hypothesize that the subsequent
advent of ‘‘professional’’ innate and adaptive immunity systems allowed NMD
and the motif-triggered mechanisms to be efficiently repurposed for regulation
of endogenous cellular transcripts. This scenario explains the rapid emergence
of archetypical mRNA destabilization pathways in eukaryotes and argues that
other aspects of post-transcriptional gene regulation in this lineage might have
been derived through a similar exaptation route.
Keywords:.antiviral defense; exaptation; mRNA decay; nonsense-mediated decay;
regnase; roquin; tristetraprolin
: Additional supporting information may be found in the online version of thisarticle at the publisher’s web-site.
Introduction
Extensive regulation of gene expression
at the post-transcriptional level is a
characteristic trait of eukaryotic biology
differentiating this domain of life from
bacteria and archaea. A compelling
example of this divergence is provided
by mRNA destabilization mechanisms
triggered by specific nucleotide and
structural elements, base-pairing be-
tween RNA molecules and unusual
patterns of mRNA translation [1–3].
When discussing mRNA decay it is
important to distinguish between the
core machinery responsible for RNA
degradation catalysis and controlled
mechanisms that target specific subsets
of mRNAs. In eukaryotes, the core
machinery contains the Xrn family 50–
30 exoribonucleases and the RNA exo-
some, a molecular complex combining
30–50 exoribonuclease and endoribonu-
clease activities [4–6]. Eukaryotic
mRNA decay is typically initiated by
shortening of the 30 poly(A) tail and
subsequent removal of the 50 cap
structure by deadenylation and decapp-
ing enzymes, respectively [6, 7].
Prokaryotes degrade their mRNAs
using a distinct set of endo- and 50–30
exoriboucleases [4, 8, 9]. Prokaryotic
mRNAs are not capped but contain a 50-
terminal triphosphate, which is re-
moved by a pyrophosphohydrolase to
facilitate subsequent degradation
steps [8, 9]. Degradation of prokaryotic
mRNAs in the 30–50 direction is cata-
lyzed by either a homomeric PNPase
(bacteria) or a heteromeric exosome
complex (archea) distantly related to
its eukaryotic counterpart [4, 8, 9].
The difference between controlled
mechanisms of mRNA decay in the two
groups is arguably even more striking.
In eukaryotes, the regulation is pro-
vided by small interfering (si), micro
(mi) and Piwi-interacting (pi) RNAs,
nonsense-mediated decay (NMD), and
RNA-binding protein-based mecha-
nisms targeting mRNAs with character-
istic sequence or secondary structure
elements for degradation [10–13]. Com-
bined with the widespread recruitment
of mRNAs to ribonucleoprotein com-
plexes [14], these mechanisms underlie
the remarkable variability in eukaryotic
mRNA half-lives ranging from minutes
to days.
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Prokaryotic logic of controlled mRNA
decay is fundamentally different [8, 9,
15]. The lack of nucleocytoplasmic
compartmentalization allows bacterial
and archaeal mRNAs to be translated in
a co-transcriptional manner. This is
typically followed by rapid clearance
of full-length mRNAs by the core
degradation machinery. A few RNA-
binding proteins (RBPs) are known to
modulate mRNA stability in prokaryotes
but the scope of this regulation is
substantially more limited compared
to eukaryotic RBPs [12, 16]. Nonetheless,
there is also evidence for transcript-
specific destabilization mechanisms in
prokaryotes. Some of these rely on
folded RNA elements acting either in
cis or in trans [8, 9, 17, 18]. One of the
most selective mechanisms of mRNA
decay in prokaryotes is provided by
some types-III and -VI CRISPR-Cas
immunity systems [19–23]. In this case,
CRISPR RNAs guide sequence-specific
degradation of pathogen-derived RNAs.
Importantly, these defense systems are
prokaryotic inventions phylogenetically
unrelated to eukaryotic RNA silencing
mechanisms.
Assuming that eukaryotes originated
through symbiosis between archaea and
bacteria and inherited a prokaryotic
version of mRNA metabolism [24], a
pertinent question is why their mRNA
degradation mechanisms diverged so
markedly from the prokaryotic roots. A
commonly held view is that segregation
of transcription and translation between
the nucleus and the cytoplasm provided
eukaryotes with a unique opportunity to
elaborate their post-transcriptional regu-
lation in the course of evolution [25].
However, most post-transcriptional
mechanisms including those controlling
mRNA destabilization are remarkably
conserved across a wide range of eukary-
otic organisms. This argues that eukar-
yotesmight have acquired a bulk of their
distinctive post-transcriptional path-
ways prior to radiation of the major
supergroups from the last common
eukaryotic ancestor (LECA) and subse-
quently explored possibilities available
within a largely established mechanistic
framework.
What could have triggered rapid
rewiring of the mRNAmetabolism in the
newly established eukaryotic domain?
Here we propose that at least some of
the mechanisms regulating eukaryotic
mRNA stability might have emerged as a
part of cellular defense against RNA
pathogens. According to this scenario,
subsequent appearance of specialized
innate and adaptive immunity systems
allowed the host cells to repurpose, or
“exapt” [26], these primeval defense
mechanisms for endogenous gene regu-
lation functions.
Eukaryotes have been
exposed to a wide range
of RNA pathogens
throughout their
evolutionary history
Viruses are exceptionally successful
pathogens using their cellular hosts as
a source of translation machinery,
nucleotides and, occasionally, struc-
tural molecules and enzymes [27–30].
Life cycles of most viruses include a
viral particle, or virion, facilitating the
spread of the infection between cells
and an intracellular stage used for
replication. Depending on the type of
nucleic acid contained in the virion and
replication mechanisms, viruses are
classified into DNA viruses with double-
and single-stranded genomes and RNA
viruses with double-stranded, positive
single-stranded (þ), and negative sin-
gle-stranded () genomes. Two addi-
tional groups containing RNA or DNA
genomes reverse-transcribe RNA as a
part of their replication cycles and are
collectively referred to as retroid vi-
ruses. RNA is also used for replication of
virus-like entities including retrotrans-
posable elements and viroids.
Although RNA-dependent viruses
have been isolated from both eukaryotic
and prokaryotic hosts, an overwhelming
majority of these pathogens infects
eukaryotes [28]. The current ICTV classi-
fication (http://www.ictvonline.org/
virusTaxonomy.asp; 2014 Release) lists
523 prokaryotic and 2666 eukaryotic
viruses. Although not an exhaustive
catalogofall knownspecies, this sizeable
samplesuggests thatRNAviruses,retroid
viruses, and viroids account for62% of
eukaryotic viral species, whereas the
corresponding figure for prokaryotes is
only1%. This striking over-representa-
tion of eukaryotic RNA pathogens does
not take into account eukaryotic
retroelements, which appear more di-
verse than such elements in bacteria [28,
31–34].
Earlier phylogenetic analyses sug-
gested that positive-strand RNA viruses
sharing picorna-like genome architec-
ture emerged through a “Big-Bang”
event preceding radiation of the major
eukaryotic supergroups [35]. This type
of viruses may have evolved through
recombination events involving a re-
verse transcriptase from a bacterial
group-II self-splicing intron and several
other components originating from the
protobacterial predecessor of eukaryotic
mitochondria [35]. Other lineages of
eukaryotic RNA-dependent viruses
might have branched off the picorna-
like tree or evolved from the two known
families of prokaryotic RNA viruses,
Leviviridae and Cystoviridae [28].
Eukaryotic retroid viruses and retro-
transposable elements likely descended
from prokaryotic retroelements [28]. It
has been proposed that prokaryotic
retrotransposable group-II introns addi-
tionally gave rise to eukaryotic spliceo-
somal introns and parts of the
spliceosomal complexes [36, 37]. Accord-
ing to different models, group-II introns
originating from the proteobacterial en-
dosymbiont colonized the host genome
eitherbeforeorafter theemergenceof the
nuclear envelope [37, 38].
Efficient defense against
RNA pathogens may
require multitier immunity
Regardless of the exact evolutionary
trajectories followed by specific groups
of viruses and retroelements, it is fair to
assume that eukaryotes have been
exposed to an increasingly wide range
of RNA-based pathogens since their
early days. If so, long-term survival of
the newly established eukaryotic line-
age would have been impossible with-
out adequate defense mechanisms.
One suchmechanismpresent inmost
extant eukaryotes and likely used by the
LECA is RNA interference (RNAi) [10,
39–45] (Fig. 1A). RNAi is triggered by
dsRNAs, which are rare in eukaryotic
cells but commonly produced during
RNA virus replication or as a result of
repeated retrotransposition events. Proc-
essing of dsRNAs by the Dicer family
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endoribonucleases generates 21-25-nt
siRNA products guiding the Argonaute
family endoribonucleases to comple-
mentary RNA targets. In addition to
Dicers and Argonautes, some eukaryotes
encode cellular RNA-dependent RNA
polymerases (RdRPs) that can amplify
the RNAi response by synthesizing sec-
ondary dsRNA triggers or siRNAs.
Metazoans use several additional
levels of antiviral defense including the
Piwi/piRNA system targeting retrotrans-
posons, innate immunity based on
recognition of pathogen-associated mo-
lecular patterns (PAMPs) by host-
encoded pattern recognition receptors
(PRRs), and immunoglobulin- and T-cell
receptor-dependent adaptive immu-
nity [46–55]. Similarly, plants have
developed sophisticated innate immu-
nity mechanisms that are largely unre-
lated to their metazoan counterparts [53,
56–59]. These examples argue that ro-
bust protection against pathogens may
require several lines of defense. Follow-
ing this logic, lasting biosafety of ances-
tral eukaryotes might have required
additional mechanisms re-enforcing
RNAi-based immunity and capable of
discriminating between non-infectious
“self” and infectious “nonself” [48]. It is
possible that such primeval mechanism-
(s) working alongside RNAi at early
stages of eukaryotic evolution were
repurposed for cellular gene regulation
and eventually lost their status of a
dedicated defense system.
RNAi itself has important functions
unrelated to immunity and might
completely forego its antiviral responsi-
bilities in many mammalian cells [52,
60]. Similarly, the miRNA pathway
sharing common evolutionary roots
with RNAi appears to be an example
of functional exaptation. miRNAs are
short single-stranded molecules pro-
duced in metazoans and plants from
endogenously encoded stem-loop pre-
cursors [10, 41, 61] (Fig. 1B). miRNA
biogenesis is catalyzed by Dicer-family
endonucleases also involved in the
RNAi pathway. Mature miRNAs func-
tion as sequence-specific guides direct-
ing repressive Argonaute-containing
complexes to their mRNA targets. This
affords global regulation of cellular
gene expression at the level of mRNA
stability and translational efficiency.
The animal and plant miRNA path-
ways appear to have evolved indepen-
dently following radiation of the
corresponding supergroups, Opistho-
konta and Archaeplastida, from a com-
mon ancestor [40]. According to a
popular model, miRNAs originated as
retrotransposon-derived and retrotrans-
poson-targeting branches of the RNAi
pathway but were subsequently repur-
posed for regulation of cell-specific
genes [52, 62, 63]. The emergence of
the piRNA/Piwi pathway in metazoans
and diversification of small RNA bio-
genesis mechanisms in plants could
have facilitated this process [41, 46, 47].
Below, we discuss the possibility that,
similar to RNAi and the miRNA path-
way, two well-characterized eukaryotic
systems regulating stability of cell-
encoded mRNAs, emerged as intrinsic
defense mechanisms against RNA
pathogens.
NMD controls mRNA
quality based on
translation termination
patterns
NMD is a conserved eukaryotic mecha-
nism destabilizing mRNAs with unusu-
ally positioned translation stop
codons [11, 64–71] (Fig. 2). NMDhas been
originallyshownto targetaberrantmRNA
species acquiring a premature termina-
tioncodon (PTC)asa result ofmutationor
splicing errors. However, it is becoming
increasingly clear that, in addition to this
error surveillance function, NMD can
control gene expression in many normal
situations ranging from maintenance of
RBP homeostasis to cellular differentia-
tion and stress response.
As discussed in several recent
reviews [11, 64–71], the NMD machinery
typicallycomprisesthekeyhelicaseUpf1,
its partners Upf2 and Upf3 and at least
one member of the Smg5-Smg6-Smg7
group of proteins recruited to activated
Upf1 and mediating target mRNA degra-
dation. In many species, the NMD
machinery also includes the Upf1 kinase
Smg1and themultisubunitexon junction
complex (EJC). These components dy-
namically interact with several addi-
tional factors including cap-binding
proteins, translation termination factors,
and mRNA degradation enzymes.
mRNAs are typically recognized as
NMD targets in the cytoplasm during
initial roundsof translation.Thepresence
of exon-exon junctions>50–55nt down-
stream of the termination codon, up-
stream ORFs in the 50UTR, or an
excessively long 30UTR increases the
likelihood of an mRNA to undergo
NMD.Mechanistic details of this pathway
differ depending on the species, and a
single organism may utilize more than
one distinct branch of NMD (Fig. 2). For
example, Upf1 appears to use several
distinct mechanisms to associate with its
mRNA targets. In many cases, it is
recruited to PTC-containing transcripts
Figure 1. A general outline of Dicer- and Argonaute-dependent post-transcriptional RNA
silencing mechanisms in eukaryotes. A: RNA interference (RNAi) pathway relying on Dicer-
dependent fragmentation of long dsRNA triggers into siRNA guides and Argonaute-
dependent cleavage on mRNAs complementary to the siRNAs. This simplified diagram does
not show RdRP-dependent steps amplifying RNAi response in some species. B: miRNA
pathway related to RNAi and using partially overlapping or paralogous RNA processing
enzymes to silence eukaryotic genes at the level of mRNA translation and/or stability.
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in an EJC-dependentmanner through the
Upf2 and/or the Upf3 adapters. This is
facilitated by direct interaction between
Upf3 and the EJC. However, Upf1 can also
interactwithmRNAs in theabsenceofEJC
with a relatively relaxed sequence speci-
ficity thus increasing the likelihood of
transcripts containing long 30UTRs to
enter theNMDpathway. Thismechanism
can induce NMD, for example, in tran-
scripts of intron-less genes and is espe-
cially widespread in intron-poor species
such as Saccharomyces cerevisiae.
Notwithstanding this functional di-
versity, genes encoding NMD and EJC
components are conserved across met-
azoans, fungi, plants, and members of
the unicellular supergroups: Amebo-
zoa, Excavata, and SAR (stramenopiles,
alveolates, Rhizaria) [72, 73]. This leaves
little doubt that the LECA had a
functional version of this mRNA desta-
bilization pathway. Although NMD is a
uniquely eukaryotic process, careful
bioinformatics analyses showed that a
PIN domain present in a subset of
endoribonuclease toxins participating
in a bacterial post-segregation cell-
killing program is conserved in some
members of the Smg5-Smg6-Smg7
group [74, 75]. Of these, metazoan
Smg6 functions as an endoribonu-
clease [4] arguing that NMD might have
evolved from an mRNA degradation
system associated with a “biological
conflict” in bacteria [38].
Interestingly, the evolutionary loss of
the NMD/EJC genes observed in some
species appears to correlate with a
reduced incidence of introns in the
corresponding genomes [72, 76]. This
argues that the evolution of introns in
ancestral eukaryoteswas possibly linked
with the presence of the EJC-dependent
branch of NMD. At least two models
rationalizing this relationship have been
put forward. According to one of them,
NMD evolved prior to expansion of
retrotransposon-like predecessors of
spliceosomal introns in the eukaryotic
genome and in fact facilitated this
process by offsetting the penalty associ-
ated with splicing errors [76]. An alterna-
tive model posits that NMD emerged
following the main wave of intron
expansion to protect the cell from
incorrectly spliced transcripts [37].
Both models assume that the ances-
tral form of NMDwas EJC-dependent and
that the EJC-independent mechanisms
appeared as its simplified derivatives in
evolutionary branches affected by large-
scale elimination of introns. However,
this scenariodoesnot account for the fact
that EJC-independent NMD is known to
occur in organisms with a normal
complement of introns. Another limita-
tion of the first model is that it does not
specify selection forces that prompted
eukaryotes to devise a sensor for exon-
exon junctions before retrotransposable
introns became a serious problem. The
secondmodel explains the emergence of
NMD as a part of the host defense against
selfish genetic elements but implies that
amulticomponentmRNAdecaypathway
was assembled virtually “from scratch”
within a relatively short period of time.
NMD might have emerged
as a broad-spectrum
defense mechanism
verifying translational
authenticity of cellular
transcripts
We believe that initial emergence of an
EJC-independent mechanism followed
by subsequent acquisition of the EJC
module might be a more plausible
scenario. The early EJC-independent
version of NMD would have been imme-
diately useful as a broad-spectrum de-
fensemechanismprotecting the host cell
against RNA viruses and retrotranspo-
sons unrelated to the group-II self-
splicing introns. Differentiation between
“self” and“nonself” in this systemwould
rely on evaluation of mRNA translation
patterns. A majority of cellular mRNAs
escapes NMD, likely as a result of
purifying selectionagainstNMD-promot-
ing features. On the other hand, RNA
pathogens must encode their replication
and gene expression functions in a
relatively small genome, limited by the
capacity of the virion or/and error-prone
nature of RNA-templated replication.
This underlying requirement for genetic
economy explains the abundance of
virus- and retrotransposon-encoded
transcripts containing multiple open
reading frames and other elements
recognized by the NMD machinery.
Recent studies argue that NMD may
be an important part of intrinsic immu-
nity in extant eukaryotes. RNAi screens
carried out by Balistreri and co-workers
identified Upf1, Smg5, and Smg7 as
factors limiting replication of þRNA
viruses from the Togaviridae family in
mammalian cells [77]. Genomic RNA in
this group of viruses typically contains
an upstream ORF encoding nonstruc-
tural proteins used for virus replication
Figure 2. A general outline of mammalian NMD including (A) EJC-dependent mechanism
and (B) EJC-independent mechanism. Note that the exact composition of the NMD
machinery may differ depending on eukaryotic group. Abbreviations: eIF, eukaryotic initiation
factor; EJC, exon junction complex; PABP, poly(A) binding protein; PTC, premature
termination codon.
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and a downstream ORF encoding struc-
tural components. The upstream ORF is
translated directly from the full-length
genome, whereas ribosomal access to
the downstream ORF requires produc-
tion of a subgenomic mRNA lacking the
upstream part. One of the consequences
of this arrangement is that the down-
stream ORF becomes a part of a long
30UTR during genomic RNA translation
thus increasing the likelihood of NMD.
Yet, removing the downstream ORF
failed to alleviate the repressive effect
of Upf1 on viral replication [77]. Thus,
other features of the viral genome may
promote recruitment of the NMD ma-
chinery, and it will be important to
identify such degradation determinants
in the future.
Antiviral effects of NMD have been
also shown in plants [78]. In this case,
Upf1, Upf3, and Smg7 (the only member
of the Smg5-Smg6-Smg7 group con-
served in Arabidopsis) inhibited replica-
tion ofþRNA viruses from the families of
Alphaflexiviridae and Tombusviridae.
Similar to Togaviridae, these viruses
use a subgenomic strategy to express a
full complement of their proteins. This
gives rise to unusually long 30UTRs in
some of the virus-encoded RNAs. The
authors showed that reducing the length
of the 30UTR in the corresponding RNA
species rescued them from the inhibitory
effect of NMD. Moreover, a þRNA virus
from the Potiviridae family containing a
single ORF and a relatively short 30UTR
escaped NMD restriction [78]. Thus, the
length of the 30UTR is an important
determinant allowing the plant NMD
system to recognize a subset of RNA
pathogens.
A study by Gloggnitzer et al. points
at a wider role of NMD in the innate
immunity in plants [79]. The authors
showed that Smg7 is required for
regulation of expression levels of a
subset of nucleotide-binding leucine-
rich repeat receptors (NLR) involved in
the host response to bacterial infection.
Loss-of-functionmutations in Arabidop-
sis Smg7 and the Upf1 genes lead to
retarded development and seedling
death as a result of elevated expression
of antibacterial defense genes [80].
Disruption of the disease resistance
signaling is sufficient to rescue these
autoimmunity-related phenotypes [80].
Interestingly, the activity of the NMD
pathway naturally declines in plants
infected by bacteria leading to increased
expression of NMD-targeted NLRs.
Upf1 has been additionally identified
asacell-encodedprotein interactingwith
bicistronic RNA of the human non-LTR
retroelement LINE-1 [81]. Knocking down
Upf1 led to a noticeable increase in the
levels of the LINE-encoded RNA and
proteins, suggesting that Upf1 is a
repressor of the retrotransposon-specific
gene expression program. However, this
treatment alsodecreased the efficiencyof
LINE-1 retrotransposition [81], a para-
doxical result awaiting follow-up analy-
ses. In any case, this study confirms that
NMD factors can mediate functional
interaction between the host and the
retrotransposon.
Ofnote, RBPs from theStaufen family
can induce an NMD-related process that
destabilizes a subset of mammalian tran-
scripts in a Upf1- and translation-depen-
dent manner [82]. Staufen is recruited to
specific 30UTR sites containing intramo-
lecular RNAhairpins, ormore frequently,
intermolecular duplexes formed by base-
pairing between complementary sequen-
ces originating from short interspersed
repeats (SINEs), retroelements propagat-
ingusingLINE-encodedreversetranscrip-
tase and endonuclease activities [32–34].
It is conceivable that Staufen-mediated
decay emerged as an offshoot of NMD
specializing in protection of the host cell
fromretrotransposon-derivedtranscripts.
Viruses often evolve mechanisms
allowing them to evade or disrupt host
defenses and this trend is certainly
apparent in the case of NMD. For
example, Rous sarcoma retrovirus con-
taining several ORFs in its genomic RNA
contains a specialized stability element
downstream of the first ORF encoding
Gag and Pol proteins [83]. This element
allows the full-length viral RNA to evade
NMD by recruiting polypyrimidine-tract
binding protein (PTBP1/PTB), an abun-
dant RBP in proliferating cells, which
this virus prefers to infect [84]. Another
member of the Retroviridae family,
human T-lymphotropic virus type 1,
inhibits the NMD machinery in part
through interaction between Upf1 and
the virus-encoded Tax protein [85].
Importantly, this stabilizes viral mRNAs
in infected cells [85].
Similarly, coat protein of hepatitis C
virus (HCV), a Flaviviridae family mem-
ber, interferes with NMD by sequestering
an EJC-associated factor, PYM1/
WIBG [86]. The role of EJC-dependent
NMD in HCV biology is unclear since this
virus replicates in the cytoplasm and
does not encode spliceosomal introns.
However, up-regulation of cell-encoded
NMD targets may contribute to patholog-
ical effects associated with HCV infec-
tion [86]. Finally, structural analysis of
the nsp10 RNA helicase encoded by
equine arteritis virus, aþRNA virus from
the order of Nidovirales, uncovered a
remarkable structural resemblance be-
tween this protein and Upf1 [87]. Al-
though the significance of this finding
still remains to be established, it is
theoretically possible that nidoviruses
employ this enzyme to interfere with the
cellular NMD machinery [88].
Tristetraprolin and related
CCCH zinc-finger proteins
might have originated as a
part of “nonself” RNA
sequence recognition
system
Another characteristic form of con-
trolled mRNA decay in eukaryotes relies
on recognition of specific sequence
motifs and structural elements present
in a subset of cellular transcripts. RBPs
containing CCCH-type zinc fingers (ZFs)
have been widely implicated in this
regulation [7, 13, 89] (Fig. 3). As the
name implies, this type of ZFs comprises
three appropriately spaced cysteines
followed by a single histidine residue.
One of the most extensively studied
members of this protein group is
mammalian Zfp36 also known as tris-
tetraprolin (TTP) [7] (Fig. 3A). TTP,
along with its paralogs Zfp36l1,
Zfp36l2, and Zfp36l3, uses a centrally
positioned tandem CCCH zinc finger
(TZF) domain to bind unstructured AU-
rich RNA elements (AREs) typically
containing one or several UAUUUAU
consensus heptamers [7]. These pro-
teins additionally contain a C-terminal
domain that can interact with the Not1
subunit of the Ccr4-Caf-Not mRNA
deadenylation complex [7]. Consistent
with this molecular feature, recruit-
ment of TTP to its mRNA targets
stimulates their deadenylation fol-
lowed by decapping and Xrn1- and
exosome-dependent degradation [7].
..... Insights & Perspectives F. M. Hamid and E. V. Makeyev
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TTP has been shown to regulate the
stability of several mammalian mRNAs
including those encoding proto-onco-
genes, growth factors, and cytokines
(including some interferons) [7]. More-
over, several brain-enriched mRNAs
containing UAUUUAU elements in their
30-untranslated regions (30UTRs) are
degraded in non-neural cells expressing
TTP at relatively high levels [90]. TTP
expression is naturally dampened dur-
ing neural differentiation by miRNA
miR-9, thus promoting accumulation
of these mRNAs and their protein
products [90]. Similarly TTP functions
as a post-transcriptional repressor of
muscle stem cell differentiation by
destabilizing mRNA of a pro-myogenic
factor, MyoD [91].
Conversely, basal levels of TTP can
transiently increase in response to toll-
like receptor (TLR) and cytokine signal-
ing [92]. Since many proinflammatory
mRNAs contain UAUUUAU motifs, this
may function as a safety mechanism
minimizing inflammation-induced tis-
sue damage. Consistent with this func-
tion, knockout mice lacking TTP
develop severe autoimmunity-related
problems due to increased expression
of one of its targets, mRNA of a potent
mediator of inflammation, tumor necro-
sis factor (TNF) a (reviewed in [13]).
Proteins containing the TTP-like TZF
domain have been identified inmetazoa,
fungi, plants, Amebozoa, and Exca-
vata [93]. Many of these proteins addi-
tionally contain the Not1-interaction
domain, which argues for conservation
of their molecular functions. Indeed, the
only Drosophila homolog of TTP called
dTIS11 has been shown to destabilize
ARE-containing targets including mRNA
of the antimicrobial peptide cecropin
A1 [94]. Several TZF proteins have been
shown to participate in stress and innate
immunity responses in Arabidopsis [89].
The fission yeast TTP homolog Zfs1 is
known to regulate stability of several
mRNAs encoding cell-cell adhesion pro-
teins, and its genetic inactivation leads to
increased cell clustering, or floccula-
tion [95]. Flocculation is considered to
be a form of stress response in yeasts
protecting the inner cells of the flocs
against environmental challenges. De-
spite the vast evolutionary distance
separating these species, theTZFdomain
of Zfs1 is functionally interchangeable
with those of its homologs of mamma-
lian, insect,plant,andfungalorigins [95].
Taken together, these data indicate that
TTP-like proteins likely evolved prior to
radiation of the main eukaryotic super-
groups and rapidly assumed regulatory
roles related to cellular stress response.
Given theprevalenceof innate immunity-
and inflammation-related targets regu-
lated by these proteins in contemporary
metazoans, one can speculate that an-
cestral forms of TTP were related to
cellular defense against RNA pathogens.
In line with this model, a large
fraction of human ARE sequences is
associated with Alu elements, an abun-
dant SINE group [96]. SINEs require a 30-
terminal polyA tail for retrotransposi-
tion, which results in the appearance of
U-rich sequences when a SINE copy is
inserted into a host gene in a reverse
orientation. These may function as TTP
sites, especially after acquiring a few U-
to-A transversions [96]. Since poly(A)
sequences are also required for mobility
of LINEs and other types of non-LTR
retrotransposons [33, 34], it is conceiv-
able that TTP-like proteins participated
in surveillance of the LECA
transcriptome for defects associated
with retrotransposon activity. Interest-
ingly, other ARE-specific regulators
including AUF1/hnRNP D and KHSRP
are also conserved across eukaryotic
supergroups ([97, 98]; and our blastp
results) and might have contributed to
this primeval defense mechanism.
Regnase and roquin
protein families might
have evolved to detect
“nonself” RNA structures
Liang et al. provide an important insight
into the CCCH ZF protein evolution [99].
The authors compared sequences of 58
such proteins encoded in the mouse
genome and identified Zc3h12 and Rc3h
among the closest relatives of the TTP
family (see Fig. 1 in [99]). Zc3h12 is
represented by four (Zc3h12a-d) and
Rc3h by two paralogs (Rc3h1/Roquin1
and Rc3h2/Roquin2) in the mouse
genome. Similar to TTP and its paralogs,
these proteins containing a single CCCH
zinc finger domain participate in regu-
lated mRNA destabilization (see below).
The Zc3h12 ZFs are especially closely
related to the TTP ZFs (see Fig. 3 in [99]).
The best-studied member of this family
is Zc3h12a, also know as MCPIP1 or
Regnase (Fig. 3B). It is known to
destabilize a subset of mRNAs including
those of pro-inflammatory cytokines IL6
and IL12b and IL1b and factors involved
in T cell activation (e.g. Icos, c-Rel, and
Ox40) [100–102]. Besides its ZF, Reg-
nase contains a catalytically active PIN
domain mediating mRNA degradation.
As mentioned above, a similar domain
is also present in the NMD endoribonu-
clease Smg6, arguing for a distant
phylogenetic relationship between the
two degradation systems. Notably, Reg-
nase has indeed been shown to destabi-
lize its targets in a Upf1-dependent
manner [103].
Regnase recognizes secondary struc-
ture elements containing a stem and a
trinucleotide loop and its PIN domain
Figure 3. CCCH-ZF-RBP pathways destabilizing mRNA containing linear sequence motifs
(TTP) or stem-loop elements (Regnase and Roquin). A: Tristetraprolin (TTP)-triggered
degradation of mRNAs containing AU-rich elements (AREs). A key step in this mechanism is
recruitment of the Ccr4-Caf-Not mRNA deadenylation complex through interaction between
TTP C-terminal domain and Not1. B: Regnase-mediated decay of mRNAs containing
characteristic stem-loop structures. This mechanism depends on Upf1 and the PIN-domain
endonuclease activity of the Regnase protein. C: Roquin targets secondary structure
elements similar to those recognized by Regnase but destabilizes mRNA by recruiting the
Ccr4-Caf-Not deadenylase.
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participates in RNA binding along with
the ZF [103, 104]. Interestingly, Roquin1
and Roquin2 proteins recognize an
overlapping set of structural elements
and promote destabilization of their
mRNA targets by recruiting the Ccr4-
Caf-Not deadenylase complex [103, 105]
(Fig. 3C). RNA binding of Roquins
depends on a conserved ROQ domain;
however, the ZF element is also required
at least for interaction with stem-loops
enriched in U [105, 106]. Notably, the
systemic immunity phenotypes of mice
lacking functional Zc3h12a/Regnase or
Rc3h1/Roquin1 genes are somewhat
evocative of the effects brought about
by the Zfp36/TTP knockout [13]. These
phylogenetic and functional similarities
among the three protein families argue
that the corresponding mRNA decay
mechanisms might have emerged from
common evolutionary roots.
Importantly, several recent studies
suggest that, in addition to its role in
cellular mRNA metabolism, Regnase
can restrict replication of þRNA viruses
from the families of Flaviviridae (HCV,
Japanese encephalitis virus, and den-
gue virus), Picornaviridae (Encephalo-
myocarditis virus) and Togaviridae
(Sindbis virus). It may also interfere
with replication of some RNA viruses
(Influenza A virus; Orthomyxoviridae)
and reverse-transcribing lentiviruses
(Human and Simian immunodeficiency
viruses; Retroviridae) [107–110]. These
activities appear to involve destabiliza-
tion of viral RNAs in a manner requiring
functional PIN and ZF domains. At least
in the case of Flaviviridae, the ZF
domain was also shown to stimulate
binding of Regnase to viral RNAs [108,
109]. Consistent with its antiviral func-
tion, Regnase expression has been
shown to increase in response to
infection and TLR signaling [109, 111].
Although cis-elements mediating
antiviral effects of Regnase are presently
unknown, efficient replication of RNA
viruses often requires conserved RNA
structures that might, at least in theory,
function as a Regnase “specificity
code.” Interestingly, repression of viral
replication by Regnase depends on the
ability of this protein to form oligom-
ers [104]. It is plausible that each of
these oligomers may simultaneously
recognize several stem-loop elements
in a single viral RNA. A conceptually
similar multipoint interaction with a
complex tertiary RNA structures has
been proposed for Zc3hav1/ZAP [112], an
interferon-inducible factor containing
four CCCH ZFs and participating in
antiviral defense as well as regulation
of some cellular transcripts [113–115].
All in all, it is tempting to speculate
that CCCH-ZF RBPs are extant descend-
ants of an ancient immunity mechanism
interferingwithRNApathogenreplication
ineukaryoticcells.Duplicating theZFunit
within a single polypeptide (as occurred
in TTP and Zc3hav1), combining it with
other RNA interaction domains (as in
Regnase and Roquins) or forming quater-
naryproteinunits (as inRegnaseandZAP)
might have extended versatility of this
system allowing it to recognize a wide
range of linear and folded RNA epitopes.
Interestingly, no prokaryotic proteins
containing more than one CCCH ZF have
been identified so far ([93]; and our blastp
results). On the other hand, some dsDNA
viruses from the Iridoviridae family and
þRNA viruses from the order of Nidovir-
ales (mentioned in thepreviouschapteras
viruses with a Upf1-like RNA helicase)
encode TZF-domain proteins of unknown
function (Table S1, Supporting Informa-
tion; also see [93]). This might be a result
of horizontal transfer of TZF sequences
between viral and cellular genomes
arguing for a special role of this protein
module in host-pathogen interactions.
Conclusions
In summary, several lines of evidence
point at possible emergence of NMD and
CCCH-ZF RBP-mediated mRNA destabi-
lization mechanisms as intrinsic immu-
nity systems. Similar to the RNAi
pathway frequently mentioned in this
context, origins of these mechanisms
likely coincided with rampant expan-
sion of RNA viruses and retroelements.
By recognizing mRNA translation pat-
terns and detecting linear and struc-
tured RNA epitopes, these evolutionary
innovations might have substantially
improved the ability of the host to
discriminate between cellular “self”
and viral “nonself.”
This scenario implies that the NMD-
and the CCCH-ZF-RBP-specific features
are continuously depleted from cell-
encoded transcripts by purifying selec-
tion. On the other hand, considerations
of genetic economy and replication
efficiency maintain these features in
RNA pathogens at a steady level. The
advent of “professional” immunity sys-
temsmight have allowed repurposing of
these post-transcriptional mechanisms
for mRNA quality control and gene
regulation in the host cell. This exapta-
tion was clearly only partial since NMD
and CCCH-ZF RBPs retain some antiviral
and immunomodulatory functions in
the present-day eukaryotes.
The multifaceted and highly inter-
twined relationship between cellular and
viral RNA metabolisms [116–118] indi-
cates that other post-transcriptional
mechanisms limiting stability, process-
ing, and translational efficiency of eu-
karyotic RNA transcripts might have
evolved via similar routes. Therefore,
one should anticipate a wider range of
mRNA degradation processes to be
uncovered in future screens for intrinsic
antiviral factors. One important predic-
tion of our hypothesis is that these novel
post-transcriptional components should
be especially abundant in simple organ-
isms lacking PRR-based and adaptive
branches of immunity but susceptible to
RNA pathogen infections.
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